EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf

View source ↗

Summary

The EMA authorised Telmisartan Actavis for the treatment of hypertension, with Actavis Group PTC ehf as the marketing authorization holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan Actavis (telmisartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Actavis Group PTC ehf. Decision date: 28/01/2025